Read + Share
Allegretti JR, Canakis A, McClure E, Marcus J, et al. Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission
Is Safe and Well-tolerated. Inflamm Bowel Dis 2021;27:2031-2033.
PMID: 34142700
|
 |
|
Allegretti JR, Canakis A, McClure E, Marcus J, et al. Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission
Is Safe and Well-tolerated. Inflamm Bowel Dis 2021;27:2031-2033.
PMID: 34142700
|
|
|
|